14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:AGTC
Delisted

Applied Genetic Technologies Corporation Stock Price (Quote)

$0.397
+0 (+0%)
At Close: Feb 28, 2023

Range Low Price High Price Comment
30 days $141.16 $183.01 Tuesday, 28th Feb 2023 AGTC stock ended at $0.397. During the day the stock fluctuated 0% from a day low at $0.397 to a day high of $0.397.
90 days $141.16 $227.30
52 weeks $84.73 $227.30

Historical Applied Genetic Technologies Corporation prices

Date Open High Low Close Volume
May 21, 2019 $3.79 $3.90 $3.77 $3.82 17 713
May 20, 2019 $3.88 $3.95 $3.65 $3.76 55 363
May 17, 2019 $3.83 $4.09 $3.81 $3.82 21 837
May 16, 2019 $3.81 $4.04 $3.78 $3.88 41 391
May 15, 2019 $4.01 $4.10 $3.54 $3.78 86 217
May 14, 2019 $4.10 $4.23 $4.01 $4.01 12 885
May 13, 2019 $4.10 $4.18 $3.80 $4.06 69 963
May 10, 2019 $4.20 $4.20 $4.08 $4.08 33 950
May 09, 2019 $4.20 $4.34 $4.08 $4.21 41 902
May 08, 2019 $4.23 $4.28 $4.12 $4.23 13 315
May 07, 2019 $4.48 $4.48 $4.06 $4.23 61 536
May 06, 2019 $4.30 $4.37 $4.18 $4.32 20 025
May 03, 2019 $4.36 $4.40 $4.28 $4.30 10 505
May 02, 2019 $4.61 $4.61 $4.30 $4.34 26 452
May 01, 2019 $4.43 $4.44 $4.01 $4.21 38 507
Apr 30, 2019 $4.53 $4.53 $4.45 $4.47 52 278
Apr 29, 2019 $4.54 $4.56 $4.42 $4.49 26 564
Apr 26, 2019 $4.56 $4.68 $4.41 $4.49 31 140
Apr 25, 2019 $4.68 $4.95 $4.59 $4.62 25 718
Apr 24, 2019 $4.75 $4.75 $4.65 $4.68 90 596
Apr 23, 2019 $4.50 $4.78 $4.50 $4.78 63 401
Apr 22, 2019 $4.60 $4.60 $4.40 $4.48 67 193
Apr 18, 2019 $4.67 $4.80 $4.51 $4.55 49 122
Apr 17, 2019 $4.73 $4.81 $4.63 $4.64 100 833
Apr 16, 2019 $4.78 $4.78 $4.70 $4.72 113 281
Click to get the best stock tips daily for free!

About Applied Genetic Technologies Corporation

Applied Genetic Technologies Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Phase I/II clinical trials; and achromatopsia that is in Phase I/II clinical trials. It is also developing... AGTC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT